References H-R

HAJA MYDIN, H., MURPHY, S., CLAGUE, H., SRIDHARAN, K. & TAYLOR, I. K. 2013. Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 8, 151-7.
HALPERN, M. T., ZILBERBERG, M. D., SCHMIER, J. K., LAU, E. C. & SHORR, A. F. 2006. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc, 4, 17.
HALPIN, D. M., DAHL, R., HALLMANN, C., MUELLER, A. & TASHKIN, D. 2015. Tiotropium HandiHaler((R)) and Respimat((R)) in COPD: a pooled safety analysis. Int J Chron Obstruct Pulmon Dis, 10, 239-59.
HAN, M. K., TAYOB, N., MURRAY, S., DRANSFIELD, M. T., WASHKO, G., SCANLON, P. D., CRINER, G. J., CASABURI, R., CONNETT, J., LAZARUS, S. C., ALBERT, R., WOODRUFF, P. & MARTINEZ, F. J. 2014. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med, 189, 1503-8.
HANANIA, N. A., CRATER, G. D., MORRIS, A. N., EMMETT, A. H., O’DELL, D. M. & NIEWOEHNER, D. E. (2012) Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. Respir Med, 106, 91-101.
HANANIA, N. A., MULLEROVA, H., LOCANTORE, N. W., VESTBO, J., WATKINS, M. L., WOUTERS, E. F., RENNARD, S. I. & SHARAFKHANEH, A. (2011) Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort. Am J Respir Crit Care Med, 183, 604-611.
HANSEL, N. N., MCCORMACK, M. C., BELLI, A. J., MATSUI, E. C., PENG, R. D., ALOE, C., PAULIN, L., WILLIAMS, D. L., DIETTE, G. B. & BREYSSE, P. N. (2013) In-home air pollution is linked to respiratory morbidity in former smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 187, 1085-90.
HAROON, S. M., JORDAN, R. E., O’BEIRNE-ELLIMAN, J. & ADAB, P. 2015. Effectiveness of case finding strategies for COPD in primary care: a systematic review and meta-analysis. NPJ Prim Care Respir Med, 25, 15056.
HARRISON, M. T., SHORT, P., WILLIAMSON, P. A., SINGANAYAGAM, A., CHALMERS, J. D. & SCHEMBRI, S. 2014. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax, 69, 609-15.
HART, J. E., LADEN, F., EISEN, E. A., SMITH, T. J. & GARSHICK, E. (2009) Chronic obstructive pulmonary disease mortality in railroad workers. Occup Environ Med, 66, 221-6.
HARTMAN, J. E., BOEZEN, H. M., DE GREEF, M. H. & TEN HACKEN, N. H. 2013. Physical and psychosocial factors associated with physical activity in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil, 94, 2396-2402 e7.
HARTMANN-BOYCE, J., LANCASTER, T. & STEAD, L. F. 2014. Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev, 6, CD001118.
HAY, J. G., STONE, P., CARTER, J., CHURCH, S., EYRE-BROOK, A., PEARSON, M. G., WOODCOCK, A. A. & CALVERLEY, P. M. (1992) Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J, 5, 659-64.
HE, Y., ZHENG, Y., XU, C., YANG, H., WANG, Z., ZHOU, L., WAN, Y., ZHENG, D. & ZHU, J. 2016. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial. Clin Respir J, 10, 318-25.
HERATH, S. C. & POOLE, P. 2013. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev, 11, CD009764.
HERTH, F. J., NOPPEN, M., VALIPOUR, A., LEROY, S., VERGNON, J. M., FICKER, J. H., EGAN, J. J., GASPARINI, S., AGUSTI, C., HOLMES-HIGGIN, D. & ERNST, A. (2012) Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J, 39, 1334-42.
HERTH, F. J., SLEBOS, D. J., RABE, K. F. & SHAH, P. L. 2016. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation. Respiration, 91, 241-50.
HIGGINS, B. G., POWELL, R. M., COOPER, S. & TATTERSFIELD, A. E. (1991) Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J, 4, 415-20.
HILL, K., GARDINER, P. A., CAVALHERI, V., JENKINS, S. C. & HEALY, G. N. 2015. Physical activity and sedentary behaviour: applying lessons to chronic obstructive pulmonary disease. Intern Med J, 45, 474-82.
HILL, K., PATMAN, S. & BROOKS, D. (2010) Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Chron Respir Dis, 7, 9-17.
HO, T. W., HUANG, C. T., CHIU, H. C., RUAN, S. Y., TSAI, Y. J., YU, C. J. & LAI, F. 2016. Effectiveness of Telemonitoring in Patients with Chronic Obstructive Pulmonary Disease in Taiwan-A Randomized Controlled Trial. Sci Rep, 6, 23797.
HOISETH, A. D., OMLAND, T., HAGVE, T. A., BREKKE, P. H. & SOYSETH, V. 2012. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort study. Respir Res, 13, 97.
HOLE, D. J., WATT, G. C., DAVEY-SMITH, G., HART, C. L., GILLIS, C. R. & HAWTHORNE, V. M. (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ, 313, 711-5; discussion 715-6.
HOLGUIN, F., FOLCH, E., REDD, S. C. & MANNINO, D. M. (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest, 128, 2005-11.
HOLLAND, A. E. & BUTTON, B. M. (2006) Is there a role for airway clearance techniques in chronic obstructive pulmonary disease? Chron Respir Dis, 3, 83-91.
HOLLAND, A. E., HILL, C. J., JONES, A. Y. & MCDONALD, C. F. (2012) Breathing exercises for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, CD008250.
HOLVERDA, S., RIETEMA, H., BOGAARD, H. J., WESTERHOF, N., POSTMUS, P. E., BOONSTRA, A. & VONK-NOORDEGRAAF, A. (2008) Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD. Pulm Pharmacol Ther, 21, 558-64.
HOMIK, J., CRANNEY, A., SHEA, B., TUGWELL, P., WELLS, G., ADACHI, R. & SUAREZ-ALMAZOR, M. (2000) Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst Rev, CD001347.
HOOGENDOORN, M., FEENSTRA, T. L., HOOGENVEEN, R. T., AL, M. & MOLKEN, M. R. (2010a) Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis, 5, 435-44.
HOOGENDOORN, M., HOOGENVEEN, R. T., RUTTEN-VAN MOLKEN, M. P., VESTBO, J. & FEENSTRA, T. L. (2010b) Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J, 37, 508-15.
HORITA, N., MIYAZAWA, N., KOJIMA, R., INOUE, M., ISHIGATSUBO, Y., UEDA, A. & KANEKO, T. 2014. Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respir Res, 15, 80.
HORITA, N., MIYAZAWA, N., TOMARU, K., INOUE, M. & KANEKO, T. 2015. Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis. Respirology, 20, 1153-9.
HORNIKX, M., VAN REMOORTEL, H., LEHOUCK, A., MATHIEU, C., MAES, K., GAYAN-RAMIREZ, G., DECRAMER, M., TROOSTERS, T. & JANSSENS, W. (2012) Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res, 13, 84.
HU, G., ZHOU, Y., TIAN, J., YAO, W., LI, J., LI, B. & RAN, P. (2010) Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest, 138, 20-31.
HUANG, S. W., WANG, W. T., CHOU, L. C., CHEN, H. C., LIOU, T. H. & LIN, H. W. 2016. Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study. Sci Rep, 6, 23360.
HUGHES, J. R., STEAD, L. F., HARTMANN-BOYCE, J., CAHILL, K. & LANCASTER, T. 2014. Antidepressants for smoking cessation. Cochrane Database Syst Rev, 1, CD000031.
HUGHES, J. R., STEAD, L. F. & LANCASTER, T. (2000) Anxiolytics for smoking cessation. Cochrane Database Syst Rev, CD002849.
HUNG, W. W., WISNIVESKY, J. P., SIU, A. L. & ROSS, J. S. (2009) Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 180, 134-7.
HUNT, T., MADIGAN, S., WILLIAMS, M. T. & OLDS, T. S. 2014. Use of time in people with chronic obstructive pulmonary disease–a systematic review. Int J Chron Obstruct Pulmon Dis, 9, 1377-88.
HUNTER, C. J., BRIGHTLING, C. E., WOLTMANN, G., WARDLAW, A. J. & PAVORD, I. D. (2002) A comparison of the validity of different diagnostic tests in adults with asthma. Chest, 121, 1051-7.
HURST, J. R., ELBORN, J. S., DE SOYZA, A. & CONSORTIUM, B.-U. 2015. COPD-bronchiectasis overlap syndrome. Eur Respir J, 45, 310-3.
HURST, J. R., VESTBO, J., ANZUETO, A., LOCANTORE, N., MULLEROVA, H., TAL-SINGER, R., MILLER, B., LOMAS, D. A., AGUSTI, A., MACNEE, W., CALVERLEY, P., RENNARD, S., WOUTERS, E. F. & WEDZICHA, J. A. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med, 363, 1128-38.
HYNNINEN, M. J., BJERKE, N., PALLESEN, S., BAKKE, P. S. & NORDHUS, I. H. (2010) A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med, 104, 986-94.
INCALZI, R. A., GEMMA, A., MARRA, C., CAPPARELLA, O., FUSO, L. & CARBONIN, P. (1997) Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest, 112, 1506-13.
ISADA CM & STOLLER JK (1994) Chronic bronchitis: the role of antibiotics. IN NIEDERMAN MS, SAROSI GA & GLASSROTH J (Eds.) Respiratory Infections: a Scientific Basis for Management. London, WB Saunders.
ISMAILA, A. S., HUISMAN, E. L., PUNEKAR, Y. S. & KARABIS, A. 2015. Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis. Int J Chron Obstruct Pulmon Dis, 10, 2495-517.
IVERSEN, K. K., KJAERGAARD, J., AKKAN, D., KOBER, L., TORP-PEDERSEN, C., HASSAGER, C., VESTBO, J. & KJOLLER, E. (2008) Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med, 264, 361-9.
IYER, A. S., BHATT, S. P., GARNER, J. J., WELLS, J. M., TREVOR, J. L., PATEL, N. M., KIRKPATRICK, D., WILLIAMS, J. C. & DRANSFIELD, M. T. 2016. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 13, 197-203.
IYER, A. S., WELLS, J. M., VISHIN, S., BHATT, S. P., WILLE, K. M. & DRANSFIELD, M. T. 2014. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest, 145, 824-32.
JAIN, V. V., ALLISON, D. R., ANDREWS, S., MEJIA, J., MILLS, P. K. & PETERSON, M. W. 2015. Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction. Lung, 193, 505-12.
JANDA, S., PARK, K., FITZGERALD, J. M., ETMINAN, M. & SWISTON, J. (2009) Statins in COPD: a systematic review. Chest, 136, 734-43.
JANSSEN, D. J., SPRUIT, M. A., SCHOLS, J. M., COX, B., NAWROT, T. S., CURTIS, J. R. & WOUTERS, E. F. (2012) Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest, 141, 1251-9.
JENKINS, C. R., CELLI, B., ANDERSON, J. A., FERGUSON, G. T., JONES, P. W., VESTBO, J., YATES, J. C. & CALVERLEY, P. M. (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J, 39, 38-45.
JENKINS, S. C., HEATON, R. W., FULTON, T. J. & MOXHAM, J. (1987) Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest, 91, 804-7.
JENNINGS, A. L., DAVIES, A. N., HIGGINS, J. P., GIBBS, J. S. & BROADLEY, K. E. (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57, 939-44.
JENNINGS, J. H., THAVARAJAH, K., MENDEZ, M. P., EICHENHORN, M., KVALE, P. & YESSAYAN, L. 2015. Predischarge bundle for patients with acute exacerbations of COPD to reduce readmissions and ED visits: a randomized controlled trial. Chest, 147, 1227-34.
JEPPESEN, E., BRURBERG, K. G., VIST, G. E., WEDZICHA, J. A., WRIGHT, J. J., GREENSTONE, M. & WALTERS, J. A. (2012) Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 5, CD003573.
JIMENEZ-RUIZ, C. A., ANDREAS, S., LEWIS, K. E., TONNESEN, P., VAN SCHAYCK, C. P., HAJEK, P., TONSTAD, S., DAUTZENBERG, B., FLETCHER, M., MASEFIELD, S., POWELL, P., HERING, T., NARDINI, S., TONIA, T. & GRATZIOU, C. 2015. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J, 46, 61-79.
JOHAL, K. S., BOULTON, C. & MORAN, C. G. 2009. Hip fractures after falls in hospital: a retrospective observational cohort study. Injury, 40, 201-4.
JONES, A., FAY, J. K., BURR, M., STONE, M., HOOD, K. & ROBERTS, G. (2002) Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003537.
JONES, A. T. & EVANS, T. W. (1997) NO: COPD and beyond. Thorax, 52 Suppl 3, S16-21.
JONES, D. A. & PETERS, T. J. (1992) Caring for elderly dependents: effects on the carers’ quality of life. Age Ageing, 21, 421-8.
JONES, P. W., ANDERSON, J. A., CALVERLEY, P. M., CELLI, B. R., FERGUSON, G. T., JENKINS, C., YATES, J. C., VESTBO, J. & SPENCER, M. D. (2011a) Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res, 12, 71.
JONES, P. W., HARDING, G., BERRY, P., WIKLUND, I., CHEN, W. H. & KLINE LEIDY, N. (2009) Development and first validation of the COPD Assessment Test. Eur Respir J, 34, 648-54.
JONES, P. W., TABBERER, M. & CHEN, W. H. 2011b. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT) scores. BMC Pulm Med, 11, 42.
JORDAN, N., LEE, T. A., VALENSTEIN, M., PIRRAGLIA, P. A. & WEISS, K. B. (2009) Effect of depression care on outcomes in COPD patients with depression. Chest, 135, 626-32.
JOSEPH, A. M., NORMAN, S. M., FERRY, L. H., PROCHAZKA, A. V., WESTMAN, E. C., STEELE, B. G., SHERMAN, S. E., CLEVELAND, M., ANTONUCCIO, D. O., HARTMAN, N. & MCGOVERN, P. G. (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med, 335, 1792-8.
JUNG, K. S., PARK, H. Y., PARK, S. Y., KIM, S. K., KIM, Y. K., SHIM, J. J., MOON, H. S., LEE, K. H., YOO, J. H. & LEE, S. D. (2012) Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study. Respir Med, 106, 382-9.
KARABIS, A., LINDNER, L., MOCARSKI, M., HUISMAN, E. & GREENING, A. (2013) Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis. Int J Chron Obstruct Pulmon Dis, 8, 405-23.
KARDOS, P., WENCKER, M., GLAAB, T. & VOGELMEIER, C. (2007) Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 175, 144-9.
KARLOH, M., FLEIG MAYER, A., MAURICI, R., PIZZICHINI, M. M., JONES, P. W. & PIZZICHINI, E. 2016. The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages. Chest, 149, 413-25.
KARNER, C. & CATES, C. J. (2011) Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD008532.
KARNER, C., CHONG, J. & POOLE, P. (2014) Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 7, CD009285.
KASTELIK, J. A., LOWE, D., STONE, R. A., BUCKINGHAM, R. J. & ROBERTS, C. M. (2012) National audit of supported discharge programmes for management of acute exacerbations of chronic obstructive pulmonary disease 2008. Thorax, 67, 371-3.
KATON, W., LIN, E. H. & KROENKE, K. (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry, 29, 147-55.
KELLY, C. A. & GIBSON, G. J. (1988) Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax, 43, 335-6.
KENNEDY, A., REEVES, D., BOWER, P., LEE, V., MIDDLETON, E., RICHARDSON, G., GARDNER, C., GATELY, C. & ROGERS, A. (2007) The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health, 61, 254-61.
KERANIS, E., MAKRIS, D., RODOPOULOU, P., MARTINOU, H., PAPAMAKARIOS, G., DANIIL, Z., ZINTZARAS, E. & GOURGOULIANIS, K. I. (2010) Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial. Eur Respir J, 36, 774-80.
KERWIN, E., HEBERT, J., GALLAGHER, N., MARTIN, C., OVEREND, T., ALAGAPPAN, V. K., LU, Y. & BANERJI, D. (2012) Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study. Eur Respir J, 40, 1106-14.
KERWIN, E. M., SCOTT-WILSON, C., SANFORD, L., RENNARD, S., AGUSTI, A., BARNES, N. & CRIM, C. 2013. A randomised trial of fluticasone furoate/vilanterol (50/25 mug; 100/25 mug) on lung function in COPD. Respir Med, 107, 560-9.
KESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B. & WEITZENBLUM, E. (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 159, 158-64.
KESTEN, S., JARA, M., WENTWORTH, C. & LANES, S. (2006) Pooled clinical trial analysis of tiotropium safety. Chest, 130, 1695-703.
KEW, K. M., DIAS, S. & CATES, C. J. 2014a. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev, 3, CD010844.
KEW, K. M., MAVERGAMES, C. & WALTERS, J. A. 2013. Long-acting beta2-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, CD010177.
KEW, K. M. & SENIUKOVICH, A. 2014b. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD010115.
KLIBER, A., LYND, L. D. & SIN, D. D. (2010) The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Respir Res, 11, 56.
KLOOSTER, K., TEN HACKEN, N. H., HARTMAN, J. E., KERSTJENS, H. A., VAN RIKXOORT, E. M. & SLEBOS, D. J. 2015. Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. N Engl J Med, 373, 2325-35.
KOBAYASHI, M., NASUHARA, Y., BETSUYAKU, T., SHIBUYA, E., TANINO, Y., TANINO, M., TAKAMURA, K., NAGAI, K., HOSOKAWA, T. & NISHIMURA, M. (2004) Effect of low-dose theophylline on airway inflammation in COPD. Respirology, 9, 249-54.
KOCH, A., PIZZICHINI, E., HAMILTON, A., HART, L., KORDUCKI, L., DE SALVO, M. C. & PAGGIARO, P. 2014. Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat(R) versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis, 9, 697-714.
KOHNLEIN, T., WINDISCH, W., KOHLER, D., DRABIK, A., GEISELER, J., HARTL, S., KARG, O., LAIER-GROENEVELD, G., NAVA, S., SCHONHOFER, B., SCHUCHER, B., WEGSCHEIDER, K., CRIEE, C. P. & WELTE, T. 2014. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med, 2, 698-705.
KOLLERT, F., TIPPELT, A., MULLER, C., JORRES, R. A., PORZELIUS, C., PFEIFER, M. & BUDWEISER, S. 2013. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care, 58, 1204-12.
KONECNY, T., PARK, J. Y., SOMERS, K. R., KONECNY, D., ORBAN, M., SOUCEK, F., PARKER, K. O., SCANLON, P. D., ASIRVATHAM, S. J., BRADY, P. A. & RIHAL, C. S. 2014. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol, 114, 272-7.
KONECNY, T., SOMERS, K., ORBAN, M., KOSHINO, Y., LENNON, R. J., SCANLON, P. D. & RIHAL, C. S. (2010) Interactions between COPD and outcomes after percutaneous coronary intervention. Chest, 138, 621-7.
KONG, G. K., BELMAN, M. J. & WEINGARTEN, S. (1997) Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest, 111, 89-94.
KORNUM, J. B., SVAERKE, C., THOMSEN, R. W., LANGE, P. & SORENSEN, H. T. (2012) Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. Respir Med, 106, 845-52.
KRAMER, N., MEYER, T. J., MEHARG, J., CECE, R. D. & HILL, N. S. (1995) Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med, 151, 1799-806.
KRISHNAN, G., GRANT, B. J., MUTI, P. C., MISHRA, A., OCHS-BALCOM, H. M., FREUDENHEIM, J. L., TREVISAN, M. & SCHUNEMANN, H. J. 2006. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med, 6, 23.
KRUIS, A. L., BOLAND, M. R., ASSENDELFT, W. J., GUSSEKLOO, J., TSIACHRISTAS, A., STIJNEN, T., BLOM, C., SONT, J. K., RUTTEN-VAN MOLKEN, M. P. & CHAVANNES, N. H. 2014. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ, 349, g5392.
KRUIS, A. L., SMIDT, N., ASSENDELFT, W. J., GUSSEKLOO, J., BOLAND, M. R., RUTTEN-VAN MOLKEN, M. & CHAVANNES, N. H. (2013) Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, CD009437.
KUNIK, M. E., BRAUN, U., STANLEY, M. A., WRISTERS, K., MOLINARI, V., STOEBNER, D. & ORENGO, C. A. (2001) One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med, 31, 717-23.
KUNIK, M. E., ROUNDY, K., VEAZEY, C., SOUCHEK, J., RICHARDSON, P., WRAY, N. P. & STANLEY, M. A. (2005) Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205-11.
LACASSE, Y., BEAUDOIN, L., ROUSSEAU, L. & MALTAIS, F. (2004) Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis, 61, 140-7.
LAHOUSSE, L., VAN DEN BOUWHUIJSEN, Q. J., LOTH, D. W., JOOS, G. F., HOFMAN, A., WITTEMAN, J. C., VAN DER LUGT, A., BRUSSELLE, G. G. & STRICKER, B. H. 2013. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med, 187, 58-64.
LANCASTER, T., STEAD, L., SILAGY, C. & SOWDEN, A. (2000) Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ, 321, 355-8.
LANCASTER, T. & STEAD, L. F. 2005. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev, CD001292.
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J. & ALMDAL, T. P. (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 160, 1856-61.
LANGE, N. E., SPARROW, D., VOKONAS, P. & LITONJUA, A. A. 2012. Vitamin D deficiency, smoking, and lung function in the Normative Aging Study. Am J Respir Crit Care Med, 186, 616-21.
LAROS, C. D., GELISSEN, H. J., BERGSTEIN, P. G., VAN DEN BOSCH, J. M., VANDERSCHUEREN, R. G., WESTERMANN, C. J. & KNAEPEN, P. J. (1986) Bullectomy for giant bullae in emphysema. J Thorac Cardiovasc Surg, 91, 63-70.
LAURIN, C., LABRECQUE, M., DUPUIS, G., BACON, S. L., CARTIER, A. & LAVOIE, K. L. (2009) Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med, 71, 667-74.
LAURIN, C., LAVOIE, K. L., BACON, S. L., DUPUIS, G., LACOSTE, G., CARTIER, A. & LABRECQUE, M. (2007) Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest, 132, 148-55.
LAURIN, C., MOULLEC, G., BACON, S. L. & LAVOIE, K. L. (2012) Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med, 185, 918-23.
LAVIOLETTE, L., LANDS, L. C., DAULETBAEV, N., SAEY, D., MILOT, J., PROVENCHER, S., LEBLANC, P. & MALTAIS, F. (2010) Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study. J Med Food, 13, 589-98.
LEE, P. N. & FRY, J. S. (2010) Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med, 8, 84.
LEE, T. A., PICKARD, A. S., AU, D. H., BARTLE, B. & WEISS, K. B. (2008) Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med, 149, 380-90.
LEE, T. A., WILKE, C., JOO, M., STROUPE, K. T., KRISHNAN, J. A., SCHUMOCK, G. T. & PICKARD, A. S. (2009) Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med, 169, 1403-10.
LEHOUCK, A., MATHIEU, C., CARREMANS, C., BAEKE, F., VERHAEGEN, J., VAN ELDERE, J., DECALLONNE, B., BOUILLON, R., DECRAMER, M. & JANSSENS, W. (2012) High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med, 156, 105-14.
LEUNG, R. W., MCKEOUGH, Z. J., PETERS, M. J. & ALISON, J. A. 2013. Short-form Sun-style t’ai chi as an exercise training modality in people with COPD. Eur Respir J, 41, 1051-7.
LEUPPI, J. D., SCHUETZ, P., BINGISSER, R., BODMER, M., BRIEL, M., DRESCHER, T., DUERRING, U., HENZEN, C., LEIBBRANDT, Y., MAIER, S., MIEDINGER, D., MULLER, B., SCHERR, A., SCHINDLER, C., STOECKLI, R., VIATTE, S., VON GARNIER, C., TAMM, M. & RUTISHAUSER, J. 2013. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA, 309, 2223-31.
LI, L. S., CAUGHEY, G. E. & JOHNSTON, K. N. 2014. The association between co-morbidities and physical performance in people with chronic obstructive pulmonary disease: a systematic review. Chron Respir Dis, 11, 3-13.
LIN, C. & PANG, Q. 2016. Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J.
LINDSON, N., AVEYARD, P. & HUGHES, J. R. 2010. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev, CD008033.
LIVERMORE, N., DIMITRI, A., SHARPE, L., MCKENZIE, D. K., GANDEVIA, S. C. & BUTLER, J. E. 2015. Cognitive behaviour therapy reduces dyspnoea ratings in patients with chronic obstructive pulmonary disease (COPD). Respir Physiol Neurobiol, 216, 35-42.
LIVERMORE, N., SHARPE, L. & MCKENZIE, D. (2010) Prevention of panic attacks and panic disorder in COPD. Eur Respir J, 35, 557-63.
LORIG, K. R., SOBEL, D. S., STEWART, A. L., BROWN, B. W., JR., BANDURA, A., RITTER, P., GONZALEZ, V. M., LAURENT, D. D. & HOLMAN, H. R. (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care, 37, 5-14.
LUCAS, A. E., SMEENK, F. J., SMEELE, I. J. & VAN SCHAYCK, O. P. (2012) Diagnostic accuracy of primary care asthma/COPD working hypotheses, a real life study. Respir Med, 106, 1158-63.
LUNG HEALTH STUDY RESEARCH GROUP (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med, 343, 1902-9.
MACFARLANE, J. T., COLVILLE, A., GUION, A., MACFARLANE, R. M. & ROSE, D. H. (1993) Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet, 341, 511-4.
MAGNUSSEN, H., WATZ, H., KIRSTEN, A., DECRAMER, M., DAHL, R., CALVERLEY, P. M., TOWSE, L., FINNIGAN, H., TETZLAFF, K. & DISSE, B. 2014. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respir Med, 108, 593-9.
MAHMARIAN, J. J., MOYE, L. A., NASSER, G. A., NAGUEH, S. F., BLOOM, M. F., BENOWITZ, N. L., VERANI, M. S., BYRD, W. G. & PRATT, C. M. (1997) Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol, 30, 125-30.
MAINGUY, V., GIRARD, D., MALTAIS, F., SAEY, D., MILOT, J., SENECHAL, M., POIRIER, P. & PROVENCHER, S. 2012. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. Am J Cardiol, 110, 258-63.
MAJOTHI, S., JOLLY, K., HENEGHAN, N. R., PRICE, M. J., RILEY, R. D., TURNER, A. M., BAYLISS, S. E., MOORE, D. J., SINGH, S. J., ADAB, P., FITZMAURICE, D. A. & JORDAN, R. E. 2015. Supported self-management for patients with COPD who have recently been discharged from hospital: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 10, 853-67.
MALEKI-YAZDI, M. R., KAELIN, T., RICHARD, N., ZVARICH, M. & CHURCH, A. 2014. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial. Respir Med, 108, 1752-60.
MALTAIS, F., CELLI, B., CASABURI, R., PORSZASZ, J., JARRETA, D., SEOANE, B. & CARACTA, C. (2011) Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med, 105, 580-7.
MANTOANI, L. C., RUBIO, N., MCKINSTRY, B., MACNEE, W. & RABINOVICH, R. A. 2016. Interventions to modify physical activity in patients with COPD: a systematic review. Eur Respir J, 48, 69-81.
MARCHETTI, N., GARSHICK, E., KINNEY, G. L., MCKENZIE, A., STINSON, D., LUTZ, S. M., LYNCH, D. A., CRINER, G. J., SILVERMAN, E. K. & CRAPO, J. D. 2014. Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. Am J Respir Crit Care Med, 190, 756-62.
MARCINIUK, D. D., BROOKS, D., BUTCHER, S., DEBIGARE, R., DECHMAN, G., FORD, G., PEPIN, V., REID, D., SHEEL, A. W., STICKLAND, M. K., TODD, D. C., WALKER, S. L., AARON, S. D., BALTER, M., BOURBEAU, J., HERNANDEZ, P., MALTAIS, F., O’DONNELL, D. E., BLEAKNEY, D., CARLIN, B., GOLDSTEIN, R., MUTHURI, S. K. & CANADIAN THORACIC SOCIETY, C. C. E. W. G. 2010. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease–practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J, 17, 159-68.
MARIN, J. M., SORIANO, J. B., CARRIZO, S. J., BOLDOVA, A. & CELLI, B. R. (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med, 182, 325-31.
MARKOULAKI, D., KOSTIKAS, K., PAPATHEODOROU, G., KOUTSOKERA, A., ALCHANATIS, M., BAKAKOS, P., GOURGOULIANIS, K. I., ROUSSOS, C., KOULOURIS, N. G. & LOUKIDES, S. 2011. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med, 22, 103-7.
MARSH, S. E., TRAVERS, J., WEATHERALL, M., WILLIAMS, M. V., ALDINGTON, S., SHIRTCLIFFE, P. M., HANSELL, A. L., NOWITZ, M. R., MCNAUGHTON, A. A., SORIANO, J. B. & BEASLEY, R. W. (2008) Proportional classifications of COPD phenotypes. Thorax, 63, 761-7.
MARTINEAU, A. R., JAMES, W. Y., HOOPER, R. L., BARNES, N. C., JOLLIFFE, D. A., GREILLER, C. L., ISLAM, K., MCLAUGHLIN, D., BHOWMIK, A., TIMMS, P. M., RAJAKULASINGAM, R. K., ROWE, M., VENTON, T. R., CHOUDHURY, A. B., SIMCOCK, D. E., WILKS, M., DEGUN, A., SADIQUE, Z., MONTEIRO, W. R., CORRIGAN, C. J., HAWRYLOWICZ, C. M. & GRIFFITHS, C. J. 2015. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med, 3, 120-30.
MARTINEZ-RIVERA, C., PORTILLO, K., MUNOZ-FERRER, A., MARTINEZ-ORTIZ, M. L., MOLINS, E., SERRA, P., RUIZ-MANZANO, J. & MORERA, J. 2012. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD, 9, 243-50.
MARTINEZ, C. H., OKAJIMA, Y., MURRAY, S., WASHKO, G. R., MARTINEZ, F. J., SILVERMAN, E. K., LEE, J. H., REGAN, E. A., CRAPO, J. D., CURTIS, J. L., HATABU, H. & HAN, M. K. 2014. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res, 15, 62.
MARTINEZ, F. J., BOSCIA, J., FELDMAN, G., SCOTT-WILSON, C., KILBRIDE, S., FABBRI, L., CRIM, C. & CALVERLEY, P. M. 2013. Fluticasone furoate/vilanterol (100/25; 200/25 mug) improves lung function in COPD: a randomised trial. Respir Med, 107, 550-9.
MARTINEZ, F. J., CALVERLEY, P. M., GOEHRING, U. M., BROSE, M., FABBRI, L. M. & RABE, K. F. 2015. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet, 385, 857-66.
MATHERS, C., VOS, T. & STEVENSON, C. (1999) The Burden of Disease and Injury in Australia, Canberra, Australian Institute of Health and Welfare.
MATHESON, M. C., BENKE, G., RAVEN, J., SIM, M. R., KROMHOUT, H., VERMEULEN, R., JOHNS, D. P., WALTERS, E. H. & ABRAMSON, M. J. (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax, 60, 645-51.
MCCARTHY, B., CASEY, D., DEVANE, D., MURPHY, K., MURPHY, E. & LACASSE, Y. 2015. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, CD003793.
MCCORD, J. & BORZAK, S. (1998) Multifocal atrial tachycardia. Chest, 113, 203-9.
MCDONALD, C. F., WHYTE, K., JENKINS, S., SERGINSON, J. & FRITH, P. 2016. Clinical Practice Guideline on Adult Domiciliary Oxygen Therapy: Executive summary from the Thoracic Society of Australia and New Zealand. Respirology, 21, 76-8.
MCEVOY, R. D., PIERCE, R. J., HILLMAN, D., ESTERMAN, A., ELLIS, E. E., CATCHESIDE, P. G., O’DONOGHUE, F. J., BARNES, D. J. & GRUNSTEIN, R. R. (2009) Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax, 64, 561-6.
MCKAY, S. E., HOWIE, C. A., THOMSON, A. H., WHITING, B. & ADDIS, G. J. (1993) Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. Thorax, 48, 227-32.
MCKEEVER, T. M., HEARSON, G., HOUSLEY, G., REYNOLDS, C., KINNEAR, W., HARRISON, T. W., KELLY, A. M. & SHAW, D. E. 2016. Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study. Thorax, 71, 210-5.
MCLEAN, S., NURMATOV, U., LIU, J. L., PAGLIARI, C., CAR, J. & SHEIKH, A. (2011) Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD007718.
MCNAMARA, RJ., MCKEOUGH, ZJ., MCKENZIE, DK., ALISON, JA. (2013a) Water-based exercise training for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD008290.
MCNAMARA, R. J., MCKEOUGH, Z. J., MCKENZIE, D. K. & ALISON, J. A. 2013b. Water-based exercise training for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, CD008290.
MCNAMARA, R. J., MCKEOUGH, Z. J., MCKENZIE, D. K. & ALISON, J. A. 2014. Physical comorbidities affect physical activity in chronic obstructive pulmonary disease: a prospective cohort study. Respirology, 19, 866-72.
MCNICHOLAS, W. T. (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med, 180, 692-700.
MEDICAL RESEARCH COUNCIL WORKING PARTY (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet, 1, 681-6.
MEECHAM JONES, D. J., PAUL, E. A., JONES, P. W. & WEDZICHA, J. A. (1995) Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med, 152, 538-44.
MEHRAN, R. J. & DESLAURIERS, J. (1995) Indications for surgery and patient work-up for bullectomy. Chest Surg Clin N Am, 5, 717-34.
MEHTA, A. J., MIEDINGER, D., KEIDEL, D., BETTSCHART, R., BIRCHER, A., BRIDEVAUX, P. O., CURJURIC, I., KROMHOUT, H., ROCHAT, T., ROTHE, T., RUSSI, E. W., SCHIKOWSKI, T., SCHINDLER, C., SCHWARTZ, J., TURK, A., VERMEULEN, R., PROBST-HENSCH, N. & KUNZLI, N. (2012) Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults. Am J Respir Crit Care Med, 185, 1292-300.
MEINE, T. J., PATEL, M. R., WASHAM, J. B., PAPPAS, P. A. & JOLLIS, J. G. (2005) Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol, 95, 976-8.
MELANI, A. S., BONAVIA, M., CILENTI, V., CINTI, C., LODI, M., MARTUCCI, P., SERRA, M., SCICHILONE, N., SESTINI, P., ALIANI, M. & NERI, M. (2011) Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med, 105, 930-8.
MERCER, S. W., SMITH, S. M., WYKE, S., O’DOWD, T. & WATT, G. C. 2009. Multimorbidity in primary care: developing the research agenda. Fam Pract, 26, 79-80.
MEYER, T. J. & HILL, N. S. (1994) Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med, 120, 760-70.
MILLER, M. R., HANKINSON, J., BRUSASCO, V., BURGOS, F., CASABURI, R., COATES, A., CRAPO, R., ENRIGHT, P., VAN DER GRINTEN, C. P., GUSTAFSSON, P., JENSEN, R., JOHNSON, D. C., MACINTYRE, N., MCKAY, R., NAVAJAS, D., PEDERSEN, O. F., PELLEGRINO, R., VIEGI, G. & WANGER, J. (2005) Standardisation of spirometry. Eur Respir J, 26, 319-38.
MIMS AUSTRALIA PTY LTD (2008) MIMS Online. Sydney, Health Communication Network.
MINISTRY OF HEALTH (2010) Mortality and Demographic Data 2007. Wellington, Ministry of Health.
MIRAVITLLES, M., ESPINOSA, C., FERNANDEZ-LASO, E., MARTOS, J. A., MALDONADO, J. A. & GALLEGO, M. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest, 116, 40-6.
MIRAVITLLES, M., FERRER, M., PONT, A., ZALACAIN, R., ALVAREZ-SALA, J. L., MASA, F., VEREA, H., MURIO, C., ROS, F. & VIDAL, R. (2004) Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax, 59, 387-95.
MIRAVITLLES, M., MORAGAS, A., HERNANDEZ, S., BAYONA, C. & LLOR, C. 2013. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest, 144, 1571-7.
MITTE, K. (2005) A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord, 88, 27-45.
MOAYYEDI, P., CONGLETON, J., PAGE, R. L., PEARSON, S. B. & MUERS, M. F. (1995) Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax, 50, 834-7.
MOGULKOC, N., KARAKURT, S., ISALSKA, B., BAYINDIR, U., CELIKEL, T., KORTEN, V. & COLPAN, N. (1999) Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med, 160, 349-53.
MOLFINO, N. A. & ZHANG, P. (2006) A meta-analysis on the efficacy of oral theophylline in patients with stable COPD. Int J Chron Obstruct Pulmon Dis, 1, 261-6.
MONTASTRUC, J. L., DURRIEU, G., SOMMET, A., DAMASE-MICHEL, C. & LAPEYRE-MESTRE, M. 2010. Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology. Br J Clin Pharmacol, 69, 561-2.
MONTERO, M., DOMINGUEZ, M., OROZCO-LEVI, M., SALVADO, M. & KNOBEL, H. (2009) Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection, 37, 16-9.
MOORE, E., PALMER, T., NEWSON, R., MAJEED, A., QUINT, J. K. & SOLJAK, M. A. 2016. Pulmonary Rehabilitation as a Mechanism to Reduce Hospitalizations for Acute Exacerbations of COPD: A Systematic Review and Meta-Analysis. Chest, 150, 837-859.
MORGAN, M. D. L., CALVERLEY, P. M. A. & CLARK, C. J. (2001) Pulmonary rehabilitation. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Thorax, 56, 827-34.
MOXHAM, J. (1988) Aminophylline and the respiratory muscles: an alternative view. Clin Chest Med, 9, 325-36.
MUKERJI, S., SHAHPURI, B., CLAYTON-SMITH, B., SMITH, N., ARMSTRONG, P., HARDY, M., MARCHANT, G. & MARSH, E. 2015. Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study. N Z Med J, 128, 34-42.
MULLEROVA, H., MASELLI, D. J., LOCANTORE, N., VESTBO, J., HURST, J. R., WEDZICHA, J. A., BAKKE, P., AGUSTI, A. & ANZUETO, A. 2015. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest, 147, 999-1007.
MURCIANO, D., AUCLAIR, M. H., PARIENTE, R. & AUBIER, M. (1989) A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med, 320, 1521-5.
MURPHY, T. F., SETHI, S., KLINGMAN, K. L., BRUEGGEMANN, A. B. & DOERN, G. V. (1999) Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis, 180, 404-9.
NADEEM, N. J., TAYLOR, S. J. & ELDRIDGE, S. M. (2011) Withdrawal of inhaled corticosteroids in individuals with COPD–a systematic review and comment on trial methodology. Respir Res, 12, 107.
NANNINI, L. J., LASSERSON, T. J. & POOLE, P. (2012) Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD006829.
NANNINI, L. J., POOLE, P., MILAN, S. J., HOLMES, R. & NORMANSELL, R. (2013a) Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 11, CD003794.
NANNINI, L. J., POOLE, P., MILAN, S. J. & KESTERTON, A. (2013b) Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 8, CD006826.
NATIONAL EMPHYSEMA TREATMENT TRIAL RESEARCH, G. (2001) Patients at High Risk of Death after Lung-Volume-Reduction Surgery. N Engl J Med, 345, 1075-1083.
NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (1998) A guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra, NHMRC.
NATIONAL HEART LUNG AND BLOOD INSTITUTE (1998) Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases [2004 edition available http://www.nhlbi.nih.gov/resources/docs/cht-book.htm]. Bethesda, MD, US Department of Health and Institutes of Health.
NETT (1999) Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg, 118, 518-28.
NG, T. P., NITI, M., TAN, W. C., CAO, Z., ONG, K. C. & ENG, P. (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med, 167, 60-7.
NHLBI/WHO WORKSHOP REPORT (April 2001) Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, National Institutes of Health – National Heart, Lung and Blood Institute.
NHS CENTRE FOR REVIEWS AND DISSEMINATION (2003) Inhaler devices for the management of asthma and COPD. Effective Healthcare: Bulletin on the Effectiveness of Health Service Interventions for Decision Makers, 8, 1-12.
NI, H., SOE, Z. & MOE, S. 2014. Aclidinium bromide for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD010509.
NICHOL, K. L., MARGOLIS, K. L., WUORENMA, J. & VON STERNBERG, T. (1994) The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med, 331, 778-84.
NIELSEN, M., BARNES, C. B. & ULRIK, C. S. 2015. Clinical characteristics of the asthma-COPD overlap syndrome–a systematic review. Int J Chron Obstruct Pulmon Dis, 10, 1443-54.
NITENBERG, A. & ANTONY, I. (1999) Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol, 34, 694-9.
NOCTURNAL OXYGEN THERAPY TRIAL GROUP (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med, 93, 391-8.
NONOYAMA, M. L., BROOKS, D., LACASSE, Y., GUYATT, G. H. & GOLDSTEIN, R. S. (2007) Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD005372.
O’BRIEN, C., GUEST, P. J., HILL, S. L. & STOCKLEY, R. A. 2000. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax, 55, 635-42.
O’DONNELL, D. E., BAIN, D. J. & WEBB, K. A. 1997. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med, 155, 530-5.
O’DONNELL, D. E., REVILL, S. M. & WEBB, K. A. (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164, 770-7.
O’DRISCOLL, B. R. (2008) Short burst oxygen therapy in patients with COPD. Monaldi Arch Chest Dis, 69, 70-4.
O’NEILL, B., MAHON, J. M. & BRADLEY, J. (2006) Short-burst oxygen therapy in chronic obstructive pulmonary disease. Respir Med, 100, 1129-38.
OBA, Y. & LONE, N. A. 2014. Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis. Int J Chron Obstruct Pulmon Dis, 9, 469-79.
OBA, Y. & LONE, N. A. 2015. Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression. Ther Adv Respir Dis, 9, 3-15.
OBA, Y., SARVA, S. T. & DIAS, S. 2016. Efficacy and safety of long-acting beta-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis. Thorax, 71, 15-25.
OGALE, S. S., LEE, T. A., AU, D. H., BOUDREAU, D. M. & SULLIVAN, S. D. (2010) Cardiovascular events associated with ipratropium bromide in COPD. Chest, 137, 13-9.
OHAR, J. A., CRATER, G. D., EMMETT, A., FERRO, T. J., MORRIS, A. N., RAPHIOU, I., SRIRAM, P. S. & DRANSFIELD, M. T. 2014. Fluticasone propionate/salmeterol 250/50 mug versus salmeterol 50 mug after chronic obstructive pulmonary disease exacerbation. Respir Res, 15, 105.
OLIVEIRA, C. C., LEE, A. L., MCGINLEY, J., THOMPSON, M., IRVING, L. B., ANDERSON, G. P., CLARK, R. A., CLARKE, S. & DENEHY, L. 2015. Falls by individuals with chronic obstructive pulmonary disease: a preliminary 12-month prospective cohort study. Respirology, 20, 1096-101.
OMACHI, T. A., KATZ, P. P., YELIN, E. H., GREGORICH, S. E., IRIBARREN, C., BLANC, P. D. & EISNER, M. D. (2009) Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med, 122, 778 e9-15.
OMLAND, O., WURTZ, E. T., AASEN, T. B., BLANC, P., BRISMAN, J. B., MILLER, M. R., PEDERSEN, O. F., SCHLUNSSEN, V., SIGSGAARD, T., ULRIK, C. S. & VISKUM, S. 2014. Occupational chronic obstructive pulmonary disease: a systematic literature review. Scand J Work Environ Health, 40, 19-35.
ORA, J., LAVENEZIANA, P., OFIR, D., DEESOMCHOK, A., WEBB, K. A. & O’DONNELL, D. E. (2009) Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med, 180, 964-71.
OSADNIK, C. R., MCDONALD, C. F., JONES, A. P. & HOLLAND, A. E. (2012) Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD008328.
OSADNIK, C. R., MCDONALD, C. F., MILLER, B. R., HILL, C. J., TARRANT, B., STEWARD, R., CHAO, C., STODDEN, N., OLIVEIRA, C. C., GAGLIARDI, N. & HOLLAND, A. E. 2014. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. Thorax, 69, 137-43.
OSBORNE, R. H., JORDAN, J. E. & ROGERS, A. (2008) A critical look at the role of self-management for people with arthritis and other chronic diseases. Nat Clin Pract Rheumatol, 4, 224-5.
PARK, H., SATOH, H., MIKI, A., URUSHIHARA, H. & SAWADA, Y. 2015. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol, 71, 1429-40.
PARK, S. K. & LARSON, J. L. 2014. The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease. J Cardiovasc Nurs, 29, 499-507.
PARKES, G., GREENHALGH, T., GRIFFIN, M. & DENT, R. (2008) Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ, 336, 598-600.
PASCOE, S., LOCANTORE, N., DRANSFIELD, M. T., BARNES, N. C. & PAVORD, I. D. 2015. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med, 3, 435-42.
PATEL, A. R., DONALDSON, G. C., MACKAY, A. J., WEDZICHA, J. A. & HURST, J. R. (2012) The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest, 141, 851-7.
PATEL, I. S., SEEMUNGAL, T. A., WILKS, M., LLOYD-OWEN, S. J., DONALDSON, G. C. & WEDZICHA, J. A. (2002) Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax, 57, 759-64.
PATEL, I. S., VLAHOS, I., WILKINSON, T. M., LLOYD-OWEN, S. J., DONALDSON, G. C., WILKS, M., REZNEK, R. H. & WEDZICHA, J. A. 2004. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 170, 400-7.
PAVORD, I. D., LETTIS, S., ANZUETO, A. & BARNES, N. 2016. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Lancet Respir Med, 4, 731-41
PEACOCK, J. L., ANDERSON, H. R., BREMNER, S. A., MARSTON, L., SEEMUNGAL, T. A., STRACHAN, D. P. & WEDZICHA, J. A. (2011) Outdoor air pollution and respiratory health in patients with COPD. Thorax, 66, 591-6.
PELLEGRINO, R., VIEGI, G., BRUSASCO, V., CRAPO, R. O., BURGOS, F., CASABURI, R., COATES, A., VAN DER GRINTEN, C. P., GUSTAFSSON, P., HANKINSON, J., JENSEN, R., JOHNSON, D. C., MACINTYRE, N., MCKAY, R., MILLER, M. R., NAVAJAS, D., PEDERSEN, O. F. & WANGER, J. (2005) Interpretative strategies for lung function tests. Eur Respir J, 26, 948-68.
PEPIN, V., BRODEUR, J., LACASSE, Y., MILOT, J., LEBLANC, P., WHITTOM, F. & MALTAIS, F. (2007) Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax, 62, 291-8.
PEPIN, V., SAEY, D., WHITTOM, F., LEBLANC, P. & MALTAIS, F. (2005) Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 172, 1517-22.
PEPPER, J. K. & BREWER, N. T. 2014. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control, 23, 375-84.
PETERS, M. J. & MORGAN, L. C. (2002) The pharmacotherapy of smoking cessation. Med J Aust, 176, 486-90.
PETO, R., SPEIZER, F. E., COCHRANE, A. L., MOORE, F., FLETCHER, C. M., TINKER, C. M., HIGGINS, I. T., GRAY, R. G., RICHARDS, S. M., GILLILAND, J. & NORMAN-SMITH, B. (1983) The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis, 128, 491-500.
PEYTREMANN-BRIDEVAUX, I., STAEGER, P., BRIDEVAUX, P. O., GHALI, W. A. & BURNAND, B. (2008) Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med, 121, 433-443 e4.
PHILLIPSON, E. A. & BOWES, G. (1986) Control of breathing during sleep. IN CHERNIACK, N. S. & WIDDICOMBE, J. G. (Eds.) Handbook of Physiology. The Respiratory System. Vol II. Control of Breathing. Bethesda, MD, American Physiological Society.
PILCHER, J., CAMERON, L., BRAITHWAITE, I., BOWLES, D., SWAIN, A., BAILEY, M., WEATHERALL, M., BEASLEY, R. & PERRIN, K. 2015. Comparative audit of oxygen use in the prehospital setting in acute COPD exacerbation over 5 years. Emerg Med J, 32, 234-8.
PINNOCK, H., HANLEY, J., MCCLOUGHAN, L., TODD, A., KRISHAN, A., LEWIS, S., STODDART, A., VAN DER POL, M., MACNEE, W., SHEIKH, A., PAGLIARI, C. & MCKINSTRY, B. 2013. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ, 347, f6070.
PITTA, F., TROOSTERS, T., SPRUIT, M. A., PROBST, V. S., DECRAMER, M. & GOSSELINK, R. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171, 972-7.
PLANT, P. K., OWEN, J. L. & ELLIOTT, M. W. (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet, 355, 1931-5.
POLLACK, M. H., KRADIN, R., OTTO, M. W., WORTHINGTON, J., GOULD, R., SABATINO, S. A. & ROSENBAUM, J. F. (1996) Prevalence of panic in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry, 153, 110-3.
POOLE, P. & BLACK, P. N. (2010) Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD001287.
POOLE, P. J., CHACKO, E., WOOD-BAKER, R. W. & CATES, C. J. (2006) Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002733.
PORTEGIES, M. L., LAHOUSSE, L., JOOS, G. F., HOFMAN, A., KOUDSTAAL, P. J., STRICKER, B. H., BRUSSELLE, G. G. & IKRAM, M. A. 2016. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med, 193, 251-8.
POSTMA, D. S., PETERS, I., STEENHUIS, E. J. & SLUITER, H. J. (1988) Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J, 1, 22-6.
POSTMA, D. S., STEENHUIS, E. J., VAN DER WEELE, L. T. & SLUITER, H. J. (1985) Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis, 67, 56-64.
POULAIN, M., DOUCET, M., DRAPEAU, V., FOURNIER, G., TREMBLAY, A., POIRIER, P. & MALTAIS, F. (2008) Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis, 5, 35-41.
POULAIN, M., DURAND, F., PALOMBA, B., CEUGNIET, F., DESPLAN, J., VARRAY, A. & PREFAUT, C. (2003) 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest, 123, 1401-7.
PUHAN MA, BACHMANN LM, KLEIJNEN J, TER RIET G, KESSELS AG. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Medicine. 2009a;7:2. doi:10.1186/1741-7015-7-2.
PUHAN, M. A., GARCIA-AYMERICH, J., FREY, M., TER RIET, G., ANTO, J. M., AGUSTI, A. G., GOMEZ, F. P., RODRIGUEZ-ROISIN, R., MOONS, K. G., KESSELS, A. G. & HELD, U. 2009b. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet, 374, 704-11.
RABE, K. F., BATEMAN, E. D., O’DONNELL, D., WITTE, S., BREDENBROKER, D. & BETHKE, T. D. (2005) Roflumilast–an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 366, 563-71.
RAM, F. S., JONES, P. W., CASTRO, A. A., DE BRITO, J. A., ATALLAH, A. N., LACASSE, Y., MAZZINI, R., GOLDSTEIN, R. & CENDON, S. (2002) Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003902.
RAM, F. S., PICOT, J., LIGHTOWLER, J. & WEDZICHA, J. A. (2004) Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD004104.
RAM, F. S. & SESTINI, P. (2003) Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Thorax, 58, 580-4.
RAMACHANDRAN, K., MCCUSKER, C., CONNORS, M., ZUWALLACK, R. & LAHIRI, B. (2008) The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis, 5, 205-9.
REA, H., KENEALY, T., ADAIR, J., ROBINSON, E. & SHERIDAN, N. (2011) Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 6, 527-32.
REA, H., MCAULEY, S., JAYARAM, L., GARRETT, J., HOCKEY, H., STOREY, L., O’DONNELL, G., HARU, L., PAYTON, M. & O’DONNELL, K. (2010) The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med, 104, 525-33.
RENNARD, S. I., SCHACHTER, N., STREK, M., RICKARD, K. & AMIT, O. (2006) Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest, 129, 56-66.
REVILL, S. M., NOOR, M. Z., BUTCHER, G. & WARD, M. J. 2010. The endurance shuttle walk test: an alternative to the six-minute walk test for the assessment of ambulatory oxygen. Chron Respir Dis, 7, 239-45.
RICE, K. L., DEWAN, N., BLOOMFIELD, H. E., GRILL, J., SCHULT, T. M., NELSON, D. B., KUMARI, S., THOMAS, M., GEIST, L. J., BEANER, C., CALDWELL, M. & NIEWOEHNER, D. E. (2010) Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med, 182, 890-6.
RICE, V. H., HARTMANN-BOYCE, J. & STEAD, L. F. 2013. Nursing interventions for smoking cessation. Cochrane Database Syst Rev, 8, CD001188.
RIES, A. L., BAULDOFF, G. S., CARLIN, B. W., CASABURI, R., EMERY, C. F., MAHLER, D. A., MAKE, B., ROCHESTER, C. L., ZUWALLACK, R. & HERRERIAS, C. (2007) Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest, 131, 4S-42S.
RIES, A. L., KAPLAN, R. M., LIMBERG, T. M. & PREWITT, L. M. (1995) Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med, 122, 823-32.
RIES, A. L., KAPLAN, R. M., MYERS, R. & PREWITT, L. M. 2003. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med, 167, 880-8.
RIES, A. L., MAKE, B. J., LEE, S. M., KRASNA, M. J., BARTELS, M., CROUCH, R. & FISHMAN, A. P. (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest, 128, 3799-809.
RIETEMA, H., HOLVERDA, S., BOGAARD, H. J., MARCUS, J. T., SMIT, H. J., WESTERHOF, N., POSTMUS, P. E., BOONSTRA, A. & VONK-NOORDEGRAAF, A. (2008) Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J, 31, 759-64.
RIVERA-FERNANDEZ, R., NAVARRETE-NAVARRO, P., FERNANDEZ-MONDEJAR, E., RODRIGUEZ-ELVIRA, M., GUERRERO-LOPEZ, F. & VAZQUEZ-MATA, G. (2006) Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med, 34, 2317-24.
RIZKALLAH, J., MAN, S. F. & SIN, D. D. (2009) Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest, 135, 786-93.
RODRIGO, G. J., CASTRO-RODRIGUEZ, J. A. & PLAZA, V. (2009) Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review. Chest, 136, 1029-38.
RODRIGO, G. J. & NEFFEN, H. 2015. A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD. Chest, 148, 397-407.
RODRIGO, G. J. & PLAZA, V. 2014. Efficacy and safety of a fixed-dose combination of indacaterol and Glycopyrronium for the treatment of COPD: a systematic review. Chest, 146, 309-17.
RODRIGUEZ, E., FERRER, J., MARTI, S., ZOCK, J. P., PLANA, E. & MORELL, F. (2008) Impact of occupational exposure on severity of COPD. Chest, 134, 1237-43.
ROEDE, B. M., BRESSER, P., BINDELS, P. J., KOK, A., PRINS, M., TER RIET, G., GESKUS, R. B., HERINGS, R. M. & PRINS, J. M. (2008) Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax, 63, 968-73.
ROEHRS, T., MERRION, M., PEDROSI, B., STEPANSKI, E., ZORICK, F. & ROTH, T. (1995) Neuropsychological function in obstructive sleep apnea syndrome (OSAS) compared to chronic obstructive pulmonary disease (COPD). Sleep, 18, 382-8.
ROIG, M., ENG, J. J., MACINTYRE, D. L., ROAD, J. D., FITZGERALD, J. M., BURNS, J. & REID, W. D. 2011. Falls in people with chronic obstructive pulmonary disease: an observational cohort study. Respir Med, 105, 461-9.
ROJAS-REYES, M. X., GARCIA MORALES, O. M., DENNIS, R. J. & KARNER, C. 2016. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, Cd008532.
ROSKELL, N. S., ANZUETO, A., HAMILTON, A., DISSE, B. & BECKER, K. 2014. Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol. Int J Chron Obstruct Pulmon Dis, 9, 813-24.
ROSSI, A., GOTTFRIED, S. B., HIGGS, B. D., ZOCCHI, L., GRASSINO, A. & MILIC-EMILI, J. (1985) Respiratory mechanics in mechanically ventilated patients with respiratory failure. J Appl Physiol, 58, 1849-58.
ROSSI, A., VAN DER MOLEN, T., DEL OLMO, R., PAPI, A., WEHBE, L., QUINN, M., LU, C., YOUNG, D., CAMERON, R., BUCCHIONI, E. & ALTMAN, P. 2014. INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J, 44, 1548-56.
RUGBJERG, M., IEPSEN, U. W., JORGENSEN, K. J. & LANGE, P. 2015. Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses. Int J Chron Obstruct Pulmon Dis, 10, 791-801.
RUTTEN, E. P., FRANSSEN, F. M., SPRUIT, M. A. & WOUTERS, E. F. 2013. Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. COPD, 10, 286-92.